直 Japanese PDF Font
  • 我们的专业人员
  • 服务
  • 我们的见解
  • 办公室
  • 事务所
  • 人才招聘
Finnegan
  • 新闻
  • 飞翰事实
  • History
    • Finnegan VISION
    • Finnegan FORWARD
  • 慈善性法律援助
  • 管理层
    • Pricing & Alternative Fee Arrangements
    • AFA Models We Offer
    • Contingency Fees
    • AI + KM

James R. Barney

Sharp Divisions Over Joint Infringement

May 9, 2011

The National Law Journal

What was once considered settled law in joint infringement in patent litigation has been changing. The National Law Journal examines this recent shift in joint infringement jurisprudence. Previous decisions held that joint infringement existed only when one person performs the steps of a patent process. But other members of the patent bar have felt that the court has effectively rendered many Internet, software, and telecommunications enabled method patents unenforceable, where different or multiple individuals participate in performing the patented process. The Federal Circuit has agreed to hear an en banc rehearing in one of its cases which could determine the validity of many of these types of patents. Donald Dunner, partner at Finnegan, weighed in that, "people have expectations that when they filed these cases they'd be able to get patent protection. Suddenly they're told there's some special rule."

Related Practices

全球知识产权维权、诉讼与审判

联邦巡回法院和最高法院上诉

Related News

Award/Ranking

Finnegan Earns Top Rankings in 2026 IAM Patent 1000 Guide; Nearly 60 Attorneys Ranked

May 28, 2026

Commentary

Quince Aims to Have ‘Dupe’ Evidence Shape Ugg Shoe Patent Trial

May 26, 2026

Award/Ranking

Finnegan Partner Antje Brambrink Shortlisted for Women in Business Law EMEA Award

May 13, 2026

Press Release

Finnegan Secures Decisive ITC Victory for Innoscience in Final Determination

May 11, 2026

Commentary

ITC Bars Import of Innoscience Chips Made Before Redesign

May 8, 2026

Commentary

How Litigation Funding Disclosure Could Affect ITC Cases

May 7 , 2026

Award/Ranking

61 Finnegan Attorneys Recognized on the 2025 Capital Pro Bono Honor Roll

May 7, 2026

Commentary

Justices to Side with Generic Drugmakers in Patent Spat, Attorneys Predict

May 5, 2026

Commentary

Supreme Court Takes Up Generic Drug Labeling Fight

April 29, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • 隐私
  • 免责申明
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP